PunditScore
Pundits › Yatin Suneja
YS

Yatin Suneja

Compare →
Managing Director, Biotechnology Analyst at Guggenheim Securities
Financial & Wall StreetBiotechnologyHealthcare

Yatin Suneja is a Managing Director and Biotechnology Analyst at Guggenheim Securities, specializing in healthcare equity research with a focus on biotechnology companies. He has over 17 years of experience in the field, having previously held senior positions at SunTrust Robinson Humphrey and Cowen and Company.

No chart yet. A chart needs 8 resolved predictions, and Yatin has 6. The predictions themselves are below.

SORT
STILL OPEN
?
Sign in to read this call.
Due Jul 17, 2027July 17, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Sign in to read this call.
Due Jul 20, 2027July 20, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Biogen will reach a price of $280 within 12 months of Jul 21, 2026.
Due Jul 21, 2027July 21, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Neurocrine Biosciences will reach a price of $200 within 12 months of Jul 21, 2026.
Due Jul 21, 2027July 21, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Regeneron Pharmaceuticals will reach a price of $1000 within 12 months of Jul 21, 2026.
Due Jul 21, 2027July 21, 2026Price targetEquitiesPending
—
SCORE
⌄
?
argenx SE will reach a price of $1135 within 12 months of Jul 21, 2026.
Due Jul 21, 2027July 21, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Phathom Pharmaceuticals will reach a price of $25 within 12 months of Jul 21, 2026.
Due Jul 21, 2027July 21, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Spyre Therapeutics will reach a price of $115 within 12 months of Jul 24, 2026.
Due Jul 24, 2027July 24, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Sionna Therapeutics will reach a price of $50 within 12 months of Jul 24, 2026.
Due Jul 24, 2027July 24, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Yatin Suneja predicts a price target of $20.00 for Zura Bio within 12 months after boosting the price target.
Due Aug 12, 2027August 12, 2026BiotechnologyPending
—
SCORE
⌄
?
Yatin Suneja predicts a price target of $55.00 for Zenas BioPharma within 12 months after reiterating the rating.
Due Aug 14, 2027August 14, 2026BiotechnologyPending
—
SCORE
⌄
?
Yatin Suneja predicts a price target of $50.00 for Latigo Biotherapeutics within 12 months after initiating coverage.
Due Sep 1, 2027September 1, 2026BiotechnologyPending
—
SCORE
⌄
?
Sign in to read this call.
July 9, 2026Price targetEquitiesPending
—
SCORE
⌄
?
Sign in to read this call.
March 20, 2026price targetdowngradePending
—
SCORE
⌄
RESOLVED · NEWEST FIRST
◇
Sign in to read this call.
March 15, 2023FinanceStockNot settleable
—
SCORE
⌄
◇
Sign in to read this call.
March 15, 2023PharmaceuticalsInvestmentNot settleable
—
SCORE
⌄
✗
Sign in to read this call.
March 6, 2023call #6FinanceBiotechnologyWrong
7
SCORE
⌄
✓
Sign in to read this call.
January 3, 2023call #5PharmaceuticalsCorrect
82
SCORE
⌄
◇
Sign in to read this call.
September 28, 2022pharmaceuticalsAlzheimer'sNo verdict
—
SCORE
⌄
◇
Sign in to read this call.
September 28, 2022pharmaceuticalsAlzheimer'sNo verdict
—
SCORE
⌄
◇
Sign in to read this call.
September 28, 2022pharmaceuticalsAlzheimer'sNo verdict
—
SCORE
⌄
◇
Sign in to read this call.
September 28, 2022pharmaceuticalsAlzheimer'sNo verdict
—
SCORE
⌄
✓
Sign in to read this call.
August 12, 2022call #4PharmaceuticalsStock PriceCorrect
85
SCORE
⌄
✓
Sign in to read this call.
May 27, 2020call #3stocksinvestmentCorrect
85
SCORE
⌄
✗
Sign in to read this call.
December 16, 2019call #2stocksinvestmentWrong
0
SCORE
⌄
◑
Sign in to read this call.
October 23, 2019call #1Alzheimer'sBiotechPartial
47
SCORE
⌄
◇
Sign in to read this call.
December 10, 2017pharmaceuticalmarket potentialNo verdict
—
SCORE
⌄

Still open · 14

THE FRONT EDGE

Not resolved, so they don’t move the score.

?
Sign in to read this call.
Due Jul 17, 2027Said July 17, 2026Price targetEquities
No market prices this claim
?
Sign in to read this call.
Due Jul 20, 2027Said July 20, 2026Price targetEquities
No market prices this claim
?
Biogen will reach a price of $280 within 12 months of Jul 21, 2026.
Due Jul 21, 2027Said July 21, 2026Price targetEquities
No market prices this claim
?
Neurocrine Biosciences will reach a price of $200 within 12 months of Jul 21, 2026.
Due Jul 21, 2027Said July 21, 2026Price targetEquities
No market prices this claim
?
Regeneron Pharmaceuticals will reach a price of $1000 within 12 months of Jul 21, 2026.
Due Jul 21, 2027Said July 21, 2026Price targetEquities
No market prices this claim
?
argenx SE will reach a price of $1135 within 12 months of Jul 21, 2026.
Due Jul 21, 2027Said July 21, 2026Price targetEquities
No market prices this claim
?
Phathom Pharmaceuticals will reach a price of $25 within 12 months of Jul 21, 2026.
Due Jul 21, 2027Said July 21, 2026Price targetEquities
No market prices this claim
?
Spyre Therapeutics will reach a price of $115 within 12 months of Jul 24, 2026.
Due Jul 24, 2027Said July 24, 2026Price targetEquities
No market prices this claim
?
Sionna Therapeutics will reach a price of $50 within 12 months of Jul 24, 2026.
Due Jul 24, 2027Said July 24, 2026Price targetEquities
No market prices this claim
?
Yatin Suneja predicts a price target of $20.00 for Zura Bio within 12 months after boosting the price target.
Due Aug 12, 2027Said August 12, 2026Biotechnology
No market prices this claim
?
Yatin Suneja predicts a price target of $55.00 for Zenas BioPharma within 12 months after reiterating the rating.
Due Aug 14, 2027Said August 14, 2026Biotechnology
No market prices this claim
?
Yatin Suneja predicts a price target of $50.00 for Latigo Biotherapeutics within 12 months after initiating coverage.
Due Sep 1, 2027Said September 1, 2026Biotechnology
No market prices this claim
?
Sign in to read this call.
Said July 9, 2026Price targetEquities
No market prices this claim
?
Sign in to read this call.
Said March 20, 2026price targetdowngrade
No market prices this claim